New Light-Based scan could speed up kidney disease diagnosis
NCT ID NCT05728216
First seen Mar 24, 2026 · Last updated Jun 23, 2026 · Updated 16 times
Summary
This study tests a new imaging technique called dynamic full-field optical coherence tomography (OCT) to analyze kidney biopsies. The goal is to see if this method can identify signs of acute kidney injury or chronic kidney disease as well as or better than standard microscope analysis. The study will enroll 50 adults who need a kidney biopsy as part of their routine care. If successful, this approach could lead to faster and more detailed diagnoses.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Hospitalier William Morey - Chalon sur Saône
RECRUITINGChalon-sur-Saône, Saône-et-Loire, 71100, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
dynamic full-field optical coherence tomography
What this could lead to
If successful, this could make kidney biopsy analysis faster and more accurate, potentially improving diagnosis and treatment decisions for kidney disease.
What could go wrong
This is a small, early-stage study (50 participants) testing a new imaging technique. It may not prove better than standard methods, and the technology may not be widely available.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.